Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Zilretta injections?

See the DrugPatentWatch profile for Zilretta

Zilretta® (buprenorphine) is a prescription medication that delivers a slow‑release, steady dose of the opioid partial agonist buprenorphine. It’s approved by the FDA for the treatment of moderate‑to‑severe chronic pain in adult patients who already require daily opioid therapy for pain management.


How it works

  • Partial agonist – Buprenorphine activates opioid receptors but produces a ceiling effect for respiratory depression, making it safer than many full‑opioid agonists when used as directed.
  • Extended‑release formulation – The drug is delivered via a single subcutaneous injection that releases medication over several weeks.

Typical dosing (per FDA labeling)

Initial dose Titration Maximum dose
2.5 mg SC (once a month) 5 mg SC (once a month) 10 mg SC (once a month)
  • Start: 2.5 mg SC once a month for patients who are opioid‑naïve or have been on a low opioid dose (≤ 30 mg morphine‑equivalent daily dose).
  • Titration: If pain is inadequately controlled and the patient is on a higher opioid dose (> 30 mg morphine‑equivalent daily dose), the dose may be increased to 5 mg SC.
  • Maximum: 10 mg SC once a month can be considered for patients who remain inadequately controlled despite 5 mg.

The exact dosing schedule is individualized by a prescriber; the above are general guidelines.


Key points to consider

Category Important considerations
Indications Chronic pain that is moderate to severe and requires daily opioid treatment; not for acute pain or opioid dependence.
Contraindications Known hypersensitivity to buprenorphine; concurrent use with potent CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) can raise serum levels.
Warnings • Risk of respiratory depression, especially when combined with other CNS depressants (e.g., alcohol, benzodiazepines, other opioids).
• Not recommended for patients with severe respiratory disorders, severe hepatic impairment, or severe renal impairment.
Side effects Common: constipation, nausea, headache, drowsiness, dizziness, and injection‑site reactions (pain, redness, swelling). Rare: respiratory depression, sedation, hypotension.
Drug interactions • CYP3A4 inhibitors (e.g., ketoconazole, itraconazole) ↑ buprenorphine levels.
• CYP3A4 inducers (e.g., rifampin) ↓ buprenorphine levels.
• Concurrent opioids or other CNS depressants ↑ risk of overdose.
• Alcohol may increase sedation and respiratory depression.
Administration Must be given by a trained healthcare professional subcutaneously; not self‑administerable.
• The syringe is pre‑filled with a 1 mg/mL solution; the dose is calculated based on the patient’s pain and opioid tolerance.
Storage Store at 2 °C–30 °C (room temperature); keep sealed.
• Do not freeze.
• Use before the expiration date.
Disposal Follow local regulations for disposal of unused medication; do not flush down the toilet.

Practical tips

  • Take your prescription as directed – Do not attempt to “short‑cycle” or skip injections.
  • Report symptoms promptly – If you experience shortness of breath, dizziness, extreme drowsiness, or any new symptoms, contact your prescriber or seek emergency care.
  • Avoid mixing with alcohol – Alcohol can potentiate sedation and respiratory depression.
  • Check for drug interactions – Inform all healthcare providers of your full medication list, including over‑the‑counter supplements.
  • Monitoring – Your prescriber may monitor pain control, opioid dose adjustments, and any side effects over time.

Bottom line

Zilretta is a long‑acting buprenorphine injection designed to provide consistent pain relief for patients already on daily opioids. It offers a safer profile compared to many full‑opioid agonists, but it still carries risks associated with opioids—especially respiratory depression and potential drug interactions. Because of its potency and the potential for serious side effects, it should only be used under close medical supervision.

Always discuss the risks, benefits, and your personal health history with your prescribing clinician before starting or changing any opioid therapy.



Other Questions About Zilretta :

Zilretta injection cost? Zilretta generic name? Zilretta cost? Zilretta price? Zilretta injection price? Zilretta patent? Zilretta generic?